Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Systematic mutagenesis reveals dominant-minor paralog configurations in the rice <i>GA2ox</i> gene family.

Frontiers in plant science·2026

Same author

Cannabis Exposure After Pregnancy and Development of Hypertension in the nuMoM2b Heart Health Study.

O&G open·2026

Same author

Extracorporeal Life Support for Post-Cardiotomy Acute Right Ventricular Failure: A Retrospective Observational Multicenter Study.

The Annals of thoracic surgery·2026

Same author

The OB-GYN Take on GPT: Objective Assessment of Artificial Intelligence Models in Patient Education.

Cureus·2026

Same author

Succession planning in medical education.

Academic medicine : journal of the Association of American Medical Colleges·2026

Same author

Outcomes in Patients Requiring Veno-Venous Extracorporeal Membrane Oxygenation After Cardiac Surgery: An Analysis From the PELS-1 Study.

Artificial organs·2026

Search research articles

Related Experiment Video

Updated: May 30, 2026

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

Left ventricular assist device in pregnancy.

Shane LaRue¹, Anthony Shanks, I-Wen Wang

¹From the Division of Cardiology, Washington University in St. Louis, St. Louis, Missouri.

Obstetrics and Gynecology

|July 20, 2011

Summary

Left ventricular assist devices (LVADs) can support pregnant patients with heart failure. This case study shows successful management of a pregnant patient with an LVAD, highlighting the importance of adherence and monitoring.

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Experiment Videos

Last Updated: May 30, 2026

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Area of Science:

Cardiology
Medical Devices
Reproductive Medicine

Background:

Left ventricular assist devices (LVADs) are increasingly used for heart failure.
Pregnancy imposes unique physiological stresses, and their impact on LVADs is not fully understood.

Observation:

An 18-year-old woman with peripartum cardiomyopathy received an LVAD.
The patient demonstrated non-adherence to medical regimens initially.
She presented at 33 weeks gestation for management and monitoring.

Findings:

The patient successfully underwent anticoagulation and inpatient surveillance.
Cesarean delivery was performed at approximately 34 weeks gestation.
The LVAD management was successful throughout the pregnancy and delivery.

Implications:

LVADs may offer a viable option for pregnant patients with severe heart failure.
Close monitoring and patient adherence are critical for successful outcomes.
Further research is needed to establish standardized protocols for LVAD use in pregnancy.